Juno gets some bad­ly need­ed re­lief af­ter a glimpse of up­beat ear­ly da­ta on JCAR017

Anx­ious to turn the page on a dead­ly se­ries of cere­bral ede­ma cas­es, Juno Ther­a­peu­tics to­day turned to an up­beat set of pre­lim­i­nary da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA